The FDA approves Genentech’s updated drug labeling for Xeloda (capecitabine) under Project Renewal Pilot Program
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…
FDA granted approval to atezolizumab for alveolar soft part sarcoma
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
Karmanos completed $48 million expansion at Farmington Hills cancer center
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
Fred Hutchinson Cancer Center received $78 million gift to support precision oncology
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
FDA approved first targeted therapy for HER2-low breast cancer
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
Wake Forest CCSG cut from 5 years to 3 as center changes leadership, administrative structure
May 27, 2022, the National Cancer Institute (NCI) truncated the just-renewed five-year Cancer Center Support Grant held by…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
Major study linked breast cancer treatment with increased risk of cardiovascular disease
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics | Women's Health
Fred Hutch and Seattle Cancer Care Alliance unite, reshaped relationship with UW Medicine
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…
The University of Virginia Cancer Center Received NCI Comprehensive Designation
On Feb. 1, 2022, University of Virginia Cancer Center announced it had been awarded a Comprehensive Cancer Center…
Study of Penn patients with decade-long leukemia remissions after CAR T cell therapy revealed new details about persistence of personalized ‘Living Drug’ cells
On Feb. 2, 2022, a new analysis of the first two patients treated in a clinical trial with…
Anixa Biosciences announced patient dosing of investigational vaccine candidate in first-of-its-kind preventative breast cancer vaccine study
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
the Fred & Pamela Buffett Cancer Center received NCI designated cancer center renewal
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
Biotechnology | Diagnostics | Disease | Environmental | Genomics | Life Science News | NIH | Oncology
NIH study illuminated origins of lung cancer in never smokers
On Sept. 6, 2021, a genomic analysis of lung cancer in people with no history of smoking has…
FDA approved Merck’s hypoxia-inducible factor-2 alpha inhibitor WELIREG (belzutifan)
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first targeted therapy for subset of non-small cell lung cancer
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
UTSW researchers identified new gene involved in breast cancer growth
On Jan. 12, 2021, a team researchers from the University of Texas Southwestern (UTSW) announced they had identified…
American Cancer Society reported largest one-year drop in cancer mortality from 1991-2017
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Radiology | Therapeutics
FDA approved first adjuvant therapy for most common type of lung cancer
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Oncology | Radiology | Therapeutics
AI detected COVID-19 on chest X-rays faster and with more accuracy than radiologists
On Nov. 24, 2020, Northwestern University researchers announced they had developed a new artificial intelligence (A.I.) platform that…
Agilent received expanded FDA approval for PD-L1 IHC 22C3 pharmDx in triple-negative breast cancer
On Nov. 13, 2020, Agilent Technologies announced it had received U.S. Food and Drug Administration (FDA) approval for…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics of breast and ovarian cancer
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
Seagen announced closing of $1.0 billion stock sale to Merck
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
Fred Hutch completed move-in of Lake Union Steam Plant
On Nov. 9, 2020, after more than two years of reconstruction efforts, scientists from the Fred Hutchinson Cancer…
Pascal Biosciences and SoRSE Technology announced partnership for cannabinoid drug development and cancer clinical trials
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…